HAMPTON, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second
quarter 2018 financial results on Wednesday, August 8, 2018 after the U.S. financial markets close. Celldex executives will host a
conference call at 4:30 p.m. EDT on the same day to review the second quarter 2018 financial results and to provide an update on
key research and development and business objectives for the remainder of 2018.
The conference call and presentation will be webcast live over the Internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of the Celldex Therapeutics website at www.celldex.com. The call can also be accessed by dialing (866) 743-9666 (within the United
States) or (760) 298-5103 (outside the United States). The passcode is 4768019.
A replay of the call will be available approximately two hours after the live call concludes through August 15, 2018. To access
the replay, dial (855) 859-2056 (within the United States) or (404) 537-3406 (outside the United States). The passcode is 4768019.
The webcast will also be archived on the Company's website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our
pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have
the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases.
Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
